AI-generated summary
This review covers phototherapy for psoriasis and atopic dermatitis, including ultraviolet light, vascular lasers and low-level light therapy. The authors report that narrowband UVB is the gold standard for these conditions based on efficacy and safety. They state that vascular lasers, intense pulsed light and low-level light therapy cannot currently be recommended because of a lack of well-controlled studies.
- Who or what was studied
- Patients with psoriasis and atopic dermatitis
- Limits stated in the abstract
- The authors state that evidence for vascular lasers, intense pulsed light and low-level light therapy lacks well-controlled studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Phototherapy, Low-level laser therapy, Photobiomodulation, Ultraviolet, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.